login

Reduced Brain Norepinephrine and Dopamine Release in Treatment-Refractory Depressive Illness

Archives of General PsychiatryPublished 1 August 2000
Gavin Lambert, Mats Johansson, Hans Ågren, Peter Friberg
Citations296

TL;DR

In accordance with the monoamine hypothesis, a deficit in brain norepinephrine and dopamine exists in patients with depressive illness and the brains of these patients use an energy source other than glucose, a situation that is normalized following the acute pharmacological blockade of the norpinephrine transporter with the tricyclic antidepressant, desipramine.

Abstract

In accordance with the monoamine hypothesis, a deficit in brain norepinephrine and dopamine exists in patients with depressive illness. Moreover, the brains of these patients use an energy source other than glucose, a situation that is normalized following the acute pharmacological blockade of the norepinephrine transporter with the tricyclic antidepressant, desipramine.

Keywords

MedicineNeuroscience